Liposomes boost drug delivery, but clinical translation lags behind

Liposomes boost drug delivery, but clinical translation lags behind
Image: Intellect (generated)

In short: A review of liposome-based drug delivery describes how these tiny, flexible lipid structures can stabilize therapeutic compounds, help them cross cellular barriers and improve how precisely drugs reach target tissues in the body, while limiting exposure to healthy tissue. Despite decades of encouraging results in preclinical studies, the authors note that turning liposome technology into widely used clinical treatments has progressed only slowly.

Liposomes' physical and chemical properties can be tuned to suit different delivery needs, making them attractive for many areas of medicine. Yet after around 50 years of research and many positive preclinical findings, moving these systems from lab to clinic has proved difficult.

This is a review summarising existing laboratory and preclinical research rather than new experiments, and it notes that significant biological and translational obstacles remain before liposomes can be widely used in patients.

Why it matters: Liposomes remain a promising but still only partially realized tool for delivering drugs more precisely in the body.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/technology-research-liposomes-offer-versatile-ways-to-improve-drug-delivery-and.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…